Drug intelligence / Profile preview

Curasept Primidenti

Development stage: Unknown
Lead developer: Curasept
Modality: Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Curasept Primidenti is a pediatric oral hygiene product line developed by Curasept S.p.A., an Italian company specializing in oral health. The line is specifically designed for infants and young children and includes a topical oral gel intended for massaging and soothing gums during the eruption of primary teeth (teething). It is marketed as a consumer oral care solution rather than a pharmaceutical drug and is often used in conjunction with accessories such as silicone finger thimbles or gum massagers to facilitate application and maintain oral hygiene in toddlers.

Brand names: Curasept Primidenti

Beyond the preview

Go deeper on Curasept Primidenti.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curasept Primidenti.

Explore the full profile